Naina Bhargava's Profile
MPharm (Master of Pharmacy)
![Naina Bhargava Naina Bhargava](https://www.medindia.net/images/content-team-medindia/naina-bhargava.jpg)
Naina Bhargava is a pharmaceutical sciences graduate and is currently pursuing a master's degree from a prestigious government university. She has a keen interest in creating compelling and crisp content, especially in the field of medicinal sciences, and is a national-level awardee for an elocution view more..
Written / Edited / Medically Reviewed
![How Cellular Mechanisms Recycle Fat and Protect Against Rare Diseases](https://www.medindia.net/health-images/rare-disease-day-2023.jpg)
How Cellular Mechanisms Recycle Fat and Protect Against Rare Diseases
The protein Spns1 helps transport fat molecules out of lysosomes, preventing harmful buildup and offering insights for rare genetic diseases.
![AI-Driven Genetics Paves the Way for Personalized Cancer Treatment](https://www.medindia.net/health-images/new-ai-detects-patients-with-high-cholesterol.jpg)
AI-Driven Genetics Paves the Way for Personalized Cancer Treatment
The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for personalized therapy.
![FDA-Approved Parkinson's Drug Could Alleviate Nicotine Withdrawal Symptoms](https://www.medindia.net/health-images/quit-smoking-beat-the-craving-with-nicotine.jpg)
FDA-Approved Parkinson's Drug Could Alleviate Nicotine Withdrawal Symptoms
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation therapy.
![Chronic Lymphocytic Leukemia: Acalabrutinib–Venetoclax Vs. Chemoimmunotherapy](https://www.medindia.net/health-images/chronic-lymphocytic-leukemia-combination.jpg)
Chronic Lymphocytic Leukemia: Acalabrutinib–Venetoclax Vs. Chemoimmunotherapy
Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic leukemia compared to chemoimmunotherapy.
![Bimagrumab: A Game-Changer for Combating Osteoporosis in Weight Loss Therapy](https://www.medindia.net/health-images/later-puberty-equals-lower-bone-density.jpg)
Bimagrumab: A Game-Changer for Combating Osteoporosis in Weight Loss Therapy
Bimagrumab, a drug originally developed for muscle loss, may help reduce the risk of osteoporosis in weight loss medication users by increasing bone tissue.